trending Market Intelligence /marketintelligence/en/news-insights/trending/O1oDLgf1j72_yrWqIH1qvg2 content esgSubNav
In This List

Baolingbao Biology Q1 profit climbs 6.7% YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Volume of Investment Research Reports on Inflation Increased in Q4 2021


Baolingbao Biology Q1 profit climbs 6.7% YOY

Baolingbao Biology Co. Ltd. said its first-quarter normalized net income was 3 fen per share, a decline of 5.2% from 3 fen per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 10.4 million yuan, an increase of 6.7% from 9.8 million yuan in the year-earlier period.

The normalized profit margin fell to 3.7% from 4.5% in the year-earlier period.

Total revenue rose 37.5% on an annual basis to 296.7 million yuan from 215.9 million yuan, and total operating expenses grew 36.1% from the prior-year period to 284.3 million yuan from 208.9 million yuan.

Reported net income came to 15.4 million yuan, or 4 fen per share, compared to 13.6 million yuan, or 4 fen per share, in the prior-year period.

As of April 27, US$1 was equivalent to 6.22 yuan.